Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06326268

Interest of Light Therapy in Hematology - The PHOTO-TREAT Study

Validation of the Improvement in the Management of Chemo-induced Mucositis in Hematology Through the Contribution of Photobiomodulation - The PHOTO-TREAT Study

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Institut de cancérologie Strasbourg Europe · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Chemo-induced mucositis is a common complication in patients treated for hematologic malignancies. They can manifest itself as a simple local irritation with erythema and inflammation but can also progress to erosions and ulcerations of the entire oral mucosa and are also responsible for an increased risk of infection in these immunocompromised patients. The only therapies currently offered are local care and intravenous analgesics. Studies in pediatric hematology show the effectiveness of prevention and low-dose laser treatment in chemo-induced mucositis, both in terms of reducing the number of mucositis developed but also in terms of reducing the grade of mucositis. This currently results in a recommendation for the use of photobiomodulation by international bodies such as ESMO (European Society for Medical Oncology).

Detailed description

During this research, the investigators aim at validating the efficacy and impact of photo-biomodulation in the management of chemo-induced mucositis in hematology department of Strasbourg Cancer Institute (ICANS).

Conditions

Interventions

TypeNameDescription
DEVICEPhototherapy system CareMin650TM* As part of preventive treatment: Photobiomodulation sessions will be carried out at a dose of 3 joules for 1 minute 51 seconds, 3 times a week (for a maximum duration of 4 to 6 weeks). * As part of curative treatment (i.e. for patients developing mucositis, from grade I): photobiomodulation will be carried out at a curative dose of 6 joules daily (for a maximum duration of 4 to 6 weeks ) for 3 minutes 34 seconds.

Timeline

Start date
2024-04-17
Primary completion
2025-09-17
Completion
2025-09-17
First posted
2024-03-22
Last updated
2024-04-22

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06326268. Inclusion in this directory is not an endorsement.